Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2004-6-8
pubmed:abstractText
Pseudomonas putida strain DOT-T1E is highly tolerant to organic solvents, with a logP(ow) (the logarithm of the partition coefficient of a solvent in a two-phase water-octanol system of > or =2.5. Solvent tolerant microorganisms can be exploited to develop double-phase (organic solvent and water) biotransformation systems in which toxic substrates or products are kept in the organic phase. We tested P. putida DOT-T1E tolerance to different aliphatic alcohols with a logP(ow) value between 2 and 4, such as decanol, nonanol, and octanol, which are potentially useful in biotransformations in double-phase systems in which compounds with a logP(ow) around 1.5 are produced. P. putida DOT-T1E responds to aliphatic alcohols as the second phase through cis-to-trans isomerization of unsaturated cis fatty acids and through efflux of these aliphatic alcohols via a series of pumps that also extrude aromatic hydrocarbons. These defense mechanisms allow P. putida DOT-T1E to survive well in the presence of high concentrations of the aliphatic alcohols, and growth with nonanol or decanol occurred at a high rate, whereas in the presence of an octanol double-phase growth was compromised. Our results support that the logP(ow) of aliphatic alcohols correlates with their toxic effects, as octanol (logP(ow) = 2.9) has more negative effects in P. putida cells than 1-nonanol (logP(ow) = 3.4) or 1-decanol (logP(ow) = 4). A P. putida DOT-T1E derivative bearing plasmid pWW0-xylE::Km transforms m-xylene (logP(ow) = 3.2) into 3-methylcatechol (logP(ow) = 1.8). The amount of 3-methylcatechol produced in an aliphatic alcohol/water bioreactor was 10- to 20-fold higher than in an aqueous medium, demonstrating the usefulness of double-phase systems for this particular biotransformation.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-10333523, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-10482510, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-10648517, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-10744688, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-10809693, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-10968630, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-11251828, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-11377761, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-11395460, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-11526042, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-12142492, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-12637735, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-12743835, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-12896994, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-12957894, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-13671378, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-1367167, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-1444381, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-14506010, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-2687253, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-7603409, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-7608060, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-7764006, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-7921251, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-9343354, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-9642183, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-9658016, http://linkedlifedata.com/resource/pubmed/commentcorrection/15184168-9783170
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0099-2240
pubmed:author
pubmed:issnType
Print
pubmed:volume
70
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3637-43
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Biotransformation in double-phase systems: physiological responses of Pseudomonas putida DOT-T1E to a double phase made of aliphatic alcohols and biosynthesis of substituted catechols.
pubmed:affiliation
Department of Biochemistry and Molecular and Cellular Biology of Plants, CSIC-Estación Experimental del Zaidín, E-18008 Granada, Spain.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't